{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T12:12:29Z","timestamp":1662984749765},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00347-019-0873-7","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T14:04:46Z","timestamp":1550844286000},"page":"518-523","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapieoptionen bei progredienter Myopie im\u00a0Kindesalter"],"prefix":"10.1007","volume":"116","author":[{"given":"L.","family":"Joachimsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A.","family":"Lagr\u00e8ze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"issue":"7","key":"873_CR1","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/bjophthalmol-2017-311266","volume":"102","author":"TR Fricke","year":"2018","unstructured":"Fricke TR, Jong M, Naidoo KS, Sankaridurg P, Naduvilath TJ, Ho SM et al (2018) Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling. Br J Ophthalmol 102(7):855\u2013862","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"873_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P et\u00a0al (2016) Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 123(5):1036\u20131042","journal-title":"Ophthalmology"},{"issue":"7","key":"873_CR3","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.ophtha.2015.03.018","volume":"122","author":"KM Williams","year":"2015","unstructured":"Williams KM, Bertelsen G, Cumberland P, Wolfram C, Verhoeven VJM, Anastasopoulos E et\u00a0al (2015) Increasing prevalence of myopia in Europe and the impact of education. Ophthalmology 122(7):1489\u20131497","journal-title":"Ophthalmology"},{"issue":"5","key":"873_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00347-017-0601-0","volume":"115","author":"W Wesemann","year":"2018","unstructured":"Wesemann W (2018) Analysis of spectacle lens prescriptions shows no increase of myopia in Germany from 2000 to 2015. Ophthalmologe 115(5):409\u2013417","journal-title":"Ophthalmologe"},{"issue":"6","key":"873_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.preteyeres.2012.06.004","volume":"31","author":"DI Flitcroft","year":"2012","unstructured":"Flitcroft DI (2012) The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res 31(6):622\u2013660","journal-title":"Prog Retin Eye Res"},{"issue":"2\u20134","key":"873_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12177-008-9013-3","volume":"1","author":"K Trier","year":"2008","unstructured":"Trier K, Munk Ribel-Madsen S, Cui D, Br\u00f8gger Christensen S (2008) Systemic 7\u2011methylxanthine in retarding axial eye growth and myopia progression: a\u00a036-month pilot study. J\u00a0Ocul Biol Dis Infor 1(2\u20134):85\u201393","journal-title":"J Ocul Biol Dis Infor"},{"key":"873_CR7","first-page":"1","volume":"200","author":"H Jensen","year":"1991","unstructured":"Jensen H (1991) Myopia progression in young school children. A prospective study of myopia progression and the effect of a\u00a0trial with bifocal lenses and beta blocker eye drops. Acta Ophthalmol 200:1\u201379","journal-title":"Acta Ophthalmol Suppl"},{"issue":"12","key":"873_CR8","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","volume":"113","author":"W-H Chua","year":"2006","unstructured":"Chua W\u2011H, Balakrishnan V, Chan Y\u2011H, Tong L, Ling Y, Quah B\u2011L et al (2006) Atropine for the treatment of childhood myopia. Ophthalmology 113(12):2285\u20132291","journal-title":"Ophthalmology"},{"issue":"2","key":"873_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A et\u00a0al (2012) Atropine for the treatment of childhood myopia: safety and efficacy of 0.5\u202f%, 0.1\u202f%, and 0.01\u202f% doses (Atropine for the Treatment of Myopia 2). Ophthalmology 119(2):347\u2013354","journal-title":"Ophthalmology"},{"issue":"2","key":"873_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","volume":"157","author":"A Chia","year":"2014","unstructured":"Chia A, Chua W\u2011H, Wen L, Fong A, Goon YY, Tan D (2014) Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01\u202f%, 0.1\u202f% and 0.5. Am J Ophthalmol 157(2):451\u2013457.e1","journal-title":"Am J Ophthalmol"},{"key":"873_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2018","unstructured":"Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E et al (2018) Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05\u202f%, 0.025\u202f%, and 0.01\u202f% atropine eye drops in myopia control. Ophthalmology 126:113. https:\/\/doi.org\/10.1016\/j.ophtha.2018.05.029","journal-title":"Ophthalmology"},{"issue":"3","key":"873_CR12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/OPX.0000000000000178","volume":"91","author":"S-M Li","year":"2014","unstructured":"Li S\u2011M, Wu S\u2011S, Kang M\u2011T, Liu Y, Jia S\u2011M, Li S\u2011Y et al (2014) Atropine slows myopia progression more in Asian than white children by meta-analysis. Optom Vis Sci 91(3):342\u2013350","journal-title":"Optom Vis Sci"},{"issue":"4","key":"873_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1055\/s-0043-121982","volume":"235","author":"MP Schittkowski","year":"2018","unstructured":"Schittkowski MP, Sturm V (2018) Atropine for the prevention of progression in myopia\u2014data, side effects, practical guidelines. Klin Monbl Augenheilkd 235(4):385\u2013391","journal-title":"Klin Monbl Augenheilkd"},{"issue":"4","key":"873_CR14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","volume":"123","author":"J Huang","year":"2016","unstructured":"Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H et al (2016) Efficacy comparison of 16 interventions for myopia control in children: a network Meta-analysis. Ophthalmology 123(4):697\u2013708","journal-title":"Ophthalmology"},{"issue":"7","key":"873_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/bjo.2008.149658","volume":"93","author":"JR Polling","year":"2009","unstructured":"Polling JR, Eijkemans MJ, Esser J, Gilles U, Kolling GH, Schulz E et al (2009) A randomised comparison of bilateral recession versus unilateral recession-resection as surgery for infantile esotropia. Br J Ophthalmol 93(7):954\u2013957","journal-title":"Br J Ophthalmol"},{"key":"873_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.oftale.2018.02.006","author":"M Diaz-Llopis","year":"2018","unstructured":"Diaz-Llopis M, Pinazo-Dur\u00e1n MD (2018) Superdiluted atropine at 0.01\u202f% reduces progression in children and adolescents. A 5 year study of safety and effectiveness. Arch Soc Esp Oftalmol. https:\/\/doi.org\/10.1016\/j.oftale.2018.02.006","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"1","key":"873_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","volume":"33","author":"P-C Wu","year":"2018","unstructured":"Wu P\u2011C, Chuang M\u2011N, Choi J, Chen H, Wu G, Ohno-Matsui K et al (2018) Update in myopia and treatment strategy of atropine use in myopia control. Eye (Lond) 33(1):3\u201313","journal-title":"Eye (Lond)"},{"issue":"2","key":"873_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clae.2016.02.005","volume":"39","author":"JS Wolffsohn","year":"2016","unstructured":"Wolffsohn JS, Calossi A, Cho P, Gifford K, Jones L, Li M et\u00a0al (2016) Global trends in myopia management attitudes and strategies in clinical practice. Cont Lens Anterior Eye 39(2):106\u2013116","journal-title":"Cont Lens Anterior Eye"},{"issue":"6","key":"873_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","volume":"135","author":"Q Gong","year":"2017","unstructured":"Gong Q, Janowski M, Luo M, Wei H, Chen B, Yang G et al (2017) Efficacy and adverse effects of atropine in childhood myopia: a meta-analysis. Jama Ophthalmol 135(6):624\u2013630","journal-title":"Jama Ophthalmol"},{"issue":"12","key":"873_CR20","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1097\/OPX.0000000000000037","volume":"90","author":"J Cooper","year":"2013","unstructured":"Cooper J, Eisenberg N, Schulman E, Wang FM (2013) Maximum atropine dose without clinical signs or symptoms. Optom Vis Sci 90(12):1467\u20131472","journal-title":"Optom Vis Sci"},{"issue":"11","key":"873_CR21","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1136\/bjophthalmol-2015-307861","volume":"100","author":"J Loughman","year":"2016","unstructured":"Loughman J, Flitcroft DI (2016) The acceptability and visual impact of 0.01\u202f% atropine in a\u00a0Caucasian population. Br J Ophthalmol 100(11):1525\u20131529","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"873_CR22","first-page":"812","volume":"119","author":"Y Nishiyama","year":"2015","unstructured":"Nishiyama Y, Moriyama M, Fukamachi M, Uchida A, Miyaushiro H, Kurata A et\u00a0al (2015) Side Effects of Low Dose Atropine. Nippon Ganka Gakkai Zasshi 119(11):812\u2013816","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"3","key":"873_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/jop.1999.15.257","volume":"15","author":"EJ German","year":"1999","unstructured":"German EJ, Wood D, Hurst MA (1999) Ocular effects of antimuscarinic compounds: is clinical effect determined by binding affinity for muscarinic receptors or melanin pigment? J\u00a0Ocul Pharmacol Ther 15(3):257\u2013269","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"873_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2015","unstructured":"Chia A, Lu Q\u2011S, Tan D (2015) Five-year clinical trial on atropine for\u00a0the\u00a0treatment of myopia 2: myopia control with atropine 0.01\u202f% Eyedrops. Ophthalmology 123(2):391\u2013399","journal-title":"Ophthalmology"},{"issue":"5","key":"873_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/jop.2011.0027","volume":"27","author":"P-C Wu","year":"2011","unstructured":"Wu P\u2011C, Yang Y\u2011H, Fang P\u2011C (2011) The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren. J\u00a0Ocul Pharmacol Ther 27(5):461\u2013466","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"873_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00417-016-3529-1","volume":"255","author":"Y-Y Sun","year":"2017","unstructured":"Sun Y\u2011Y, Li S\u2011M, Li S\u2011Y, Kang M\u2011T, Liu L\u2011R, Meng B et al (2017) Effect of uncorrection versus full correction on myopia progression in 12-year-old children. Graefes Arch Clin Exp Ophthalmol 255(1):189\u2013195","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"873_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1444-0938.2006.00055.x","volume":"89","author":"D Adler","year":"2006","unstructured":"Adler D, Millodot M (2006) The possible effect of undercorrection on myopic progression in children. Clin Exp Optom 89(5):315\u2013321","journal-title":"Clin Exp Optom"},{"issue":"22","key":"873_CR28","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/S0042-6989(02)00258-4","volume":"42","author":"K Chung","year":"2002","unstructured":"Chung K, Mohidin N, O\u2019Leary DJ (2002) Undercorrection of myopia enhances rather than inhibits myopia progression. Vision Res 42(22):2555\u20132559","journal-title":"Vision. Res."},{"key":"873_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004916.pub3","author":"JJ Walline","year":"2011","unstructured":"Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD (2011) Interventions to slow progression of myopia in children. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD004916.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"873_CR30","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1167\/iovs.02-0816","volume":"44","author":"J Gwiazda","year":"2003","unstructured":"Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D et\u00a0al (2003) A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci 44(4):1492\u20131500","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"873_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.survophthal.2011.06.002","volume":"56","author":"S-M Li","year":"2011","unstructured":"Li S\u2011M, Ji Y\u2011Z, Wu S\u2011S, Zhan S\u2011Y, Wang B, Liu L\u2011R et al (2011) Multifocal versus single vision lenses intervention to slow progression of myopia in school-age children: a\u00a0meta-analysis. Surv Ophthalmol 56(5):451\u2013460","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"873_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/bjophthalmol-2013-303914","volume":"98","author":"CSY Lam","year":"2014","unstructured":"Lam CSY, Tang WC, Tse DY-Y, Tang YY, To CH (2014) Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a\u00a02-year randomised clinical trial. Br J Ophthalmol 98(1):40\u201345","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"873_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/OPX.0000000000000808","volume":"93","author":"TA Aller","year":"2016","unstructured":"Aller TA, Liu M, Wildsoet CF (2016) Myopia control with bifocal contact lenses: a randomized clinical trial. Optom Vis Sci 93(4):344\u2013352","journal-title":"Optom Vis Sci"},{"issue":"6","key":"873_CR34","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/OPX.0000000000001078","volume":"94","author":"MA Bullimore","year":"2017","unstructured":"Bullimore MA (2017) The safety of soft contact lenses in children. Optom Vis Sci 94(6):638\u2013646","journal-title":"Optom Vis Sci"},{"issue":"3","key":"873_CR35","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1167\/iovs.16-20594","volume":"58","author":"P Cho","year":"2017","unstructured":"Cho P, Cheung S\u2011W (2017) Protective role of orthokeratology in reducing risk of rapid axial elongation: a reanalysis of data from the ROMIO and TO-SEE studies. Invest Ophthalmol Vis Sci 58(3):1411\u20131416","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"873_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2415-14-40","volume":"14","author":"H-J Lin","year":"2014","unstructured":"Lin H\u2011J, Wan L, Tsai F\u2011J, Tsai Y\u2011Y, Chen L\u2011A, Tsai AL et al (2014) Overnight orthokeratology is comparable with atropine in controlling myopia. BMC Ophthalmol 14:40","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"873_CR37","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.1167\/iovs.13-12527","volume":"54","author":"C Chen","year":"2013","unstructured":"Chen C, Cheung SW, Cho P (2013) Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci 54(10):6510\u20136517","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"873_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/ICL.0000000000000520","volume":"44","author":"MJ Lipson","year":"2018","unstructured":"Lipson MJ, Brooks MM, Koffler BH (2018) The role of orthokeratology in myopia control: a review. Eye Contact Lens 44(4):224\u2013230","journal-title":"Eye Contact Lens"},{"issue":"6","key":"873_CR39","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/OPX.0b013e318293657d","volume":"90","author":"J Charm","year":"2013","unstructured":"Charm J, Cho P (2013) High myopia-partial reduction ortho-k: a\u00a02-year randomized study. Optom Vis Sci 90(6):530\u2013539","journal-title":"Optom Vis Sci"},{"issue":"1","key":"873_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/02713680590907256","volume":"30","author":"P Cho","year":"2005","unstructured":"Cho P, Cheung SW, Edwards M (2005) The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a\u00a0pilot study on refractive changes and myopic control. Curr Eye Res 30(1):71\u201380","journal-title":"Curr Eye Res"},{"issue":"7","key":"873_CR41","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1167\/iovs.11-8453","volume":"53","author":"T Hiraoka","year":"2012","unstructured":"Hiraoka T, Kakita T, Okamoto F, Takahashi H, Oshika T (2012) Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a\u00a05-year follow-up study. Invest Ophthalmol Vis Sci 53(7):3913\u20133919","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"873_CR42","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1167\/iovs.10-5485","volume":"52","author":"T Kakita","year":"2011","unstructured":"Kakita T, Hiraoka T, Oshika T (2011) Influence of overnight orthokeratology on axial elongation in childhood myopia. Invest Ophthalmol Vis Sci 52(5):2170\u20132174","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"873_CR43","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1167\/iovs.11-8005","volume":"53","author":"J Santodomingo-Rubido","year":"2012","unstructured":"Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Guti\u00e9rrez-Ortega R (2012) Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes. Invest Ophthalmol Vis Sci 53(8):5060\u20135065","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"873_CR44","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/bjo.2008.151365","volume":"93","author":"JJ Walline","year":"2009","unstructured":"Walline JJ, Jones LA, Sinnott LT (2009) Corneal reshaping and myopia progression. Br J Ophthalmol 93(9):1181\u20131185","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"873_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/ICL.0b013e3180515299","volume":"34","author":"J Tsukiyama","year":"2008","unstructured":"Tsukiyama J, Miyamoto Y, Higaki S, Fukuda M, Shimomura Y (2008) Changes in the anterior and posterior radii of the corneal curvature and anterior chamber depth by orthokeratology. Eye Contact Lens 34(1):17\u201320","journal-title":"Eye Contact Lens"},{"issue":"3","key":"873_CR46","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1167\/iovs.12-10434","volume":"54","author":"S-W Cheung","year":"2013","unstructured":"Cheung S\u2011W, Cho P (2013) Validity of axial length measurements for monitoring myopic progression in orthokeratology. Invest Ophthalmol Vis Sci 54(3):1613\u20131615","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"873_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.clae.2016.12.002","volume":"40","author":"P Cho","year":"2017","unstructured":"Cho P, Cheung SW (2017) Discontinuation of orthokeratology on eyeball elongation (DOEE). Cont Lens Anterior Eye 40(2):82\u201387","journal-title":"Cont Lens Anterior Eye"},{"issue":"6 Pt 2","key":"873_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/ICL.0b013e318157cd8d","volume":"33","author":"KG Watt","year":"2007","unstructured":"Watt KG, Swarbrick HA (2007) Trends in microbial keratitis associated with orthokeratology. Eye Contact Lens 33(6 Pt 2):373\u2013377 (discussion 382)","journal-title":"Eye Contact Lens"},{"issue":"5","key":"873_CR49","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/02713683.2015.1050743","volume":"41","author":"S-M Li","year":"2016","unstructured":"Li S\u2011M, Kang M\u2011T, Wu S\u2011S, Liu L\u2011R, Li H, Chen Z et al (2016) Efficacy, safety and acceptability of orthokeratology on slowing axial elongation in myopic children by meta-analysis. Curr Eye Res 41(5):600\u2013608","journal-title":"Curr Eye Res"},{"issue":"9","key":"873_CR50","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/OPX.0b013e31829cac92","volume":"90","author":"MA Bullimore","year":"2013","unstructured":"Bullimore MA, Sinnott LT, Jones-Jordan LA (2013) The risk of microbial keratitis with overnight corneal reshaping lenses. Optom Vis Sci 90(9):937\u2013944","journal-title":"Optom Vis Sci"},{"issue":"1","key":"873_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/ICL.0000000000000219","volume":"42","author":"YM Liu","year":"2016","unstructured":"Liu YM, Xie P (2016) The safety of orthokeratology\u2014a systematic review. Eye Contact Lens 42(1):35\u201342","journal-title":"Eye Contact Lens"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-019-0873-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-0873-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-0873-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T11:40:33Z","timestamp":1662982833000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-019-0873-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["873"],"URL":"https:\/\/doi.org\/10.1007\/s00347-019-0873-7","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"22 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"W.A.\u00a0Lagr\u00e8ze weist auf folgende Beziehungen hin: Forschungsf\u00f6rderung BMBF, DFG, Referentenhonorar Alcon, Santhera, MedUpdate. Beratung Santhera, Allergan, Boehringer-Ingelheim, Merz. L.\u00a0Joachimsen gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}